4D Molecular Therapeutics, (FDMT) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
146
Total Shares Held
46.86M
Total Value
$261.85M
Institutional Holding %
84.35%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
Institution | Shares | Ownership % | Value |
---|---|---|---|
BlackRock | 4.92M | 8.86% | $27.41M |
RA | 4.56M | 8.21% | $25.42M |
GOLDMANCHS | 4.27M | 7.70% | $23.81M |
VR ADVISER | 2.95M | 5.31% | $16.44M |
VANGUARD | 2.86M | 5.15% | $15.93M |
BVF | 2.67M | 4.81% | $14.88M |
JANUS HENDERSON | 2.25M | 4.05% | $12.54M |
MORGAN STANLEY | 1.86M | 3.35% | $10.38M |
NOVO A/S | 1.50M | 2.70% | $8.36M |
MILLENNIUM | 1.42M | 2.56% | $7.91M |
Recent Insider Trading
Insider | Title | Transaction | Shares | Value | Date |
---|---|---|---|---|---|
Bizily Scott | Chief Legal Officer | A-Award | 78.50K | $324.99K | Mar 06, 2025 |
Kirn David | Director, Chief Executive Officer | A-Award | 267.50K | $1.11M | Mar 06, 2025 |
Kim Robert Young | Chief Medical Officer | A-Award | 92.30K | $382.12K | Mar 06, 2025 |
Mehra Uneek | See Remarks | A-Award | 130.00K | $538.20K | Mar 06, 2025 |
Kamal Fariborz | President & Coo | A-Award | 178.40K | $738.58K | Mar 06, 2025 |
Ra Capital Management, L.P. | 10 Percent Owner | J-Other | 535.00K | $- | Dec 09, 2024 |
Ra Capital Management, L.P. | 10 Percent Owner | J-Other | 535.00K | $54 | Dec 09, 2024 |
Ra Capital Management, L.P. | 10 Percent Owner | - | $- | Nov 13, 2024 | |
Ra Capital Management, L.P. | 10 Percent Owner | 3.08M | $308 | Nov 13, 2024 | |
Ra Capital Management, L.P. | 10 Percent Owner | 3.64M | $- | Nov 13, 2024 |
Recent Position Changes
Institution | Shares Changed | % Change | Date |
---|---|---|---|
BVF | -4.71M | -63.83% | Feb 14, 2025 |
DEEP TRACK | -3.49M | -85.11% | Feb 14, 2025 |
VR ADVISER | -1.45M | -32.90% | Feb 14, 2025 |
MILLENNIUM | +1.34M | +1607.07% | Feb 14, 2025 |
STATE STREET | -1.00M | -47.43% | Feb 14, 2025 |
ASSENAGON ASSET S.A. | -889.88K | -57.66% | Jan 14, 2025 |
JANUS HENDERSON | -884.85K | -28.21% | Feb 14, 2025 |
GOLDMANCHS | +683.94K | +19.05% | Feb 11, 2025 |
DEUTSCHE BANK\ | -560.78K | -69.87% | Feb 14, 2025 |
RA | -535.00K | -10.49% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Mar 10, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Dec 10, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Dec 06, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 15, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Nov 13, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 21, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Sep 18, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Aug 21, 2024
Related Metrics
Explore detailed financial metrics and analysis for FDMT.